Phathom Pharmaceuticals PHAT
$4.66 −$0.42 (-8.27%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.66 0.00%
Open$4.93
Prev close$5.08
Day range$4.62 – $5.15
Volume1.33M
Market cap$378.82M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$16.90+262.7% vs. price
- Buy 83%
- Hold 17%
Low $7.50Now $4.66Avg $16.90High $26.00
Recent rating changes
The last 20 actions on file set price targets from $7.50 to $28.00, averaging $20.74.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 2 Nov 2026 | Leerink Partners | HOLD | $7.50 |
| 30 Oct 2026 | H.C. Wainwright | BUY | $26.00 |
| 30 Oct 2026 | Barclays | BUY | $14.00 |
| 29 Oct 2026 | Guggenheim | BUY | $22.00 |
| 23 Oct 2026 | Cantor Fitzgerald | BUY | – |
| 21 Oct 2026 | Craig-Hallum | BUY | $15.00 |
| 21 Sep 2026 | H.C. Wainwright | BUY | $26.00 |
| 9 Sep 2026 | Leerink Partners | HOLD | $10.00 |
| 17 Aug 2026 | Barclays | BUY | $14.00 |
| 31 Jul 2026 | Craig-Hallum | BUY | $20.00 |
| 31 Jul 2026 | Raymond James | BUY | $21.00 |
| 31 Jul 2026 | Guggenheim | BUY | $22.00 |
| 31 Jul 2026 | H.C. Wainwright | BUY | $26.00 |
| 30 Jul 2026 | Needham | BUY | $22.00 |
| 21 Jul 2026 | Needham | BUY | $28.00 |
| 21 Jul 2026 | Guggenheim | BUY | $25.00 |
| 13 Jul 2026 | Craig-Hallum | BUY | – |
| 23 Jun 2026 | Craig-Hallum | BUY | – |
| 17 Jun 2026 | H.C. Wainwright | BUY | $26.00 |
| 1 Jun 2026 | Needham | BUY | $28.00 |
No comments yet — be the first to weigh in on PHAT.
Sign in to join the discussion.